Pramipexole (Mirapex), a dopamine agonist, is indicated in the treatment of:
insomnia and parasomnia disorders.
Parkinson disease and sleep-related eating disorders.
REM sleep behavior disorder and multiple sclerosis.
restless leg syndrome and Parkinson disease.
restless leg syndrome and Parkinson disease.
The patient who requires the LEAST cautionary measures when treated with
carbidopa/levodopa (Sinemet) is:
a 43-year-old woman with hypothyroidism.
a 45-year-old retired marine with secondary parkinsonism and a history of
post-traumatic stress disorder.
a 50-year-old woman with a history of obstructive sleep apnea.
a 55-year-old man with history a of myocardial infarction with residual
atrial arrhythmia.
a 43-year-old woman with hypothyroidism.
Benztropine (Cogentin), an anticholinergic, is NOT recommended for use in
patients with:
athetosis movements.
Huntington's chorea.
parkinsonism.
tardive dyskinesia.
tardive dyskinesia.
A patient presenting with a transient ischemic attack (TIA) is taking
nifedipine (Adalat CC) for hypertension. Pharmacokinetics of nifedipine may
be altered in patients with:
renal insufficiency.
hepatic impairment.
irritable bowel disease.
G6PD deficiency.
hepatic impairment.
, A medication used in a patient with a transient ischemic attack to prevent
platelet aggregation and produce an anti-inflammatory effect in vessels by
inhibiting prostaglandin synthesis is:
acetaminophen.
ibuprofen.
acetylsalicylic acid.
warfarin.
acetylsalicylic acid.
Carbidopa/levodopa (Sinemet) for the treatment of Parkinson's disease is
contraindicated in patients with:
diabetes.
history of peptic ulcer disease.
narrow-angle glaucoma.
wide-angle glaucoma.
narrow-angle glaucoma.
During initiation of treatment and escalation of doses, pramipexole
(Mirapex) and other dopamine agonists are known to cause:
akathisia.
gastrointestinal bleeding.
orthostatic hypotension.
thrombocytopenia.
orthostatic hypotension.
Ergotamine alkaloids, such as dihydroergotamine (Migranal), are indicated
in the treatment of:
basilar migraine headaches.
cluster headaches.
migraine headaches (acute).
tension headaches.
migraine headaches (acute).
Patients who are taking rasagiline (Azilect) for the treatment of
Parkinson's disease should avoid other CYP1A2 inhibitors such as:
ciprofloxacin (Cipro).
insomnia and parasomnia disorders.
Parkinson disease and sleep-related eating disorders.
REM sleep behavior disorder and multiple sclerosis.
restless leg syndrome and Parkinson disease.
restless leg syndrome and Parkinson disease.
The patient who requires the LEAST cautionary measures when treated with
carbidopa/levodopa (Sinemet) is:
a 43-year-old woman with hypothyroidism.
a 45-year-old retired marine with secondary parkinsonism and a history of
post-traumatic stress disorder.
a 50-year-old woman with a history of obstructive sleep apnea.
a 55-year-old man with history a of myocardial infarction with residual
atrial arrhythmia.
a 43-year-old woman with hypothyroidism.
Benztropine (Cogentin), an anticholinergic, is NOT recommended for use in
patients with:
athetosis movements.
Huntington's chorea.
parkinsonism.
tardive dyskinesia.
tardive dyskinesia.
A patient presenting with a transient ischemic attack (TIA) is taking
nifedipine (Adalat CC) for hypertension. Pharmacokinetics of nifedipine may
be altered in patients with:
renal insufficiency.
hepatic impairment.
irritable bowel disease.
G6PD deficiency.
hepatic impairment.
, A medication used in a patient with a transient ischemic attack to prevent
platelet aggregation and produce an anti-inflammatory effect in vessels by
inhibiting prostaglandin synthesis is:
acetaminophen.
ibuprofen.
acetylsalicylic acid.
warfarin.
acetylsalicylic acid.
Carbidopa/levodopa (Sinemet) for the treatment of Parkinson's disease is
contraindicated in patients with:
diabetes.
history of peptic ulcer disease.
narrow-angle glaucoma.
wide-angle glaucoma.
narrow-angle glaucoma.
During initiation of treatment and escalation of doses, pramipexole
(Mirapex) and other dopamine agonists are known to cause:
akathisia.
gastrointestinal bleeding.
orthostatic hypotension.
thrombocytopenia.
orthostatic hypotension.
Ergotamine alkaloids, such as dihydroergotamine (Migranal), are indicated
in the treatment of:
basilar migraine headaches.
cluster headaches.
migraine headaches (acute).
tension headaches.
migraine headaches (acute).
Patients who are taking rasagiline (Azilect) for the treatment of
Parkinson's disease should avoid other CYP1A2 inhibitors such as:
ciprofloxacin (Cipro).
